*Faculty of Medicine and Health, School of Pharmacy, University of Sydney;
‡Marie Bashir Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia;
§Kibong'oto Infectious Disease Hospital, Moshi, Tanzania;
¶Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia; and
║Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Correspondence: Jan-Willem C. Alffenaar, PhD, University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Pharmacy Building A15, NSW 2006, Australia (e-mail: [email protected]).
S. K. Heysell and P. Rao were supported by the National Institutes of Health, grant R01 AI137080. A. -G. Märtson was funded by Marie Skłodowska-Curie Actions (grant number 713660-PRONKJEWAIL-H2020-MSCA-COFUND-2015). K. C. Byashalira and S. G. Mpagama were funded by the Danish Ministry of Foreign Affairs (DFC File No. 17-03-KU). SGM received financial support from the EDCTP2 program supported by a European Union project (grant number TMA2016SF-1463-REMODELTZ). Other authors none declared.
The authors declare no conflict of interest.
K. C. Byashalira, S. K. Heysell, A. -G. Märtson, S. G. Mpagama, P. Rao, M. G. G. Sturkenboom contributed equally, authors listed in alphabetical order.